These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S. J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690 [Abstract] [Full Text] [Related]
5. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders BJ, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE. Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263 [Abstract] [Full Text] [Related]
8. Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis. Rudramurthy SM, Seyedmousavi S, Dhaliwal M, Chakrabarti A, Meis JF, Mouton JW. Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821453 [Abstract] [Full Text] [Related]
12. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis. Liu W, Sun Y, Chen W, Liu W, Wan Z, Bu D, Li R. Antimicrob Agents Chemother; 2012 May; 56(5):2598-603. PubMed ID: 22314539 [Abstract] [Full Text] [Related]
13. Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery. Verghese S, Chellamma T, Cherian KM. Mycoses; 2009 Jan; 52(1):91-3. PubMed ID: 18522699 [Abstract] [Full Text] [Related]
17. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Denning DW, Griffiths CE. Clin Exp Dermatol; 2001 Nov; 26(8):648-53. PubMed ID: 11722447 [Abstract] [Full Text] [Related]
18. Change in the clinical antifungal sensitivity profile of Aspergillus flavus induced by azole and a benzimidazole fungicide exposure. Meireles LM, de Araujo ML, Endringer DC, Fronza M, Scherer R. Diagn Microbiol Infect Dis; 2019 Oct; 95(2):171-178. PubMed ID: 31239090 [Abstract] [Full Text] [Related]
19. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance. Takeda K, Suzuki J, Watanabe A, Arai T, Koiwa T, Shinfuku K, Narumoto O, Kawashima M, Fukami T, Tamura A, Nagai H, Matsui H, Kamei K. Med Mycol; 2021 Apr 06; 59(4):327-334. PubMed ID: 32642756 [Abstract] [Full Text] [Related]
20. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method. Mello E, Posteraro B, Vella A, De Carolis E, Torelli R, D'Inzeo T, Verweij PE, Sanguinetti M. Antimicrob Agents Chemother; 2017 Jun 06; 61(6):. PubMed ID: 28416538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]